CROSSROADS STRATEGIES, LLC

Lobbying for MADRIGAL PHARMACEUTICALS, INC. · biopharmaceutical company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Pennsylvania · House · Senate · $20,000.00 income · posted Oct 19, 2025

Lobbying activity 1

Health Issues

Issues related to drug pricing.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem